To quantify signal abnormalities in the hippocampus (Hsig) of patients with systemic lupus erythematosus (SLE) and to determine if Hsig predict hippocampal atrophy (HA) in SLE.
Methods
We included all SLE patients and healthy age- and sex-matched individuals with two magnetic resonance imaging (MRI) scans performed with a minimum of 1 year interval. All individuals underwent a standardized neuropsychological evaluation. Individual results were converted into standard scores and compared to normative data. SLE patients were additionally assessed for disease activity (SLE Disease Activity Index (SLEDAI)), damage (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI)), and the presence of antiphospholipid antibodies. MRI was performed on an Elscint 2 T scanner and T1 inversion recovery and T2 coronal images were used for analysis. Volumetric (HV) and signal quantification (Hsig) were determined by standardized protocols.
Results
We included 54 SLE patients (48 women; mean age 32.2 ± 10.56 years). Hsig were found at study entry in 15 (45.5%) patients. Hsig in the body and tail of non-atrophic hippocampi correlated with progression of volume loss during the follow-up period (r = 0.8, p < 0.001). The presence of Hsig in the head of atrophic hippocampi correlated with progression of HA (r = 0.73, p = 0.005) during the same period. No correlation of Hsig and disease activity or prednisone dose was observed.
Conclusion
HA is frequently observed in SLE patients and volume loss is progressive in a subgroup of patients. The evaluation of Hsig is an easy tool to determine patients that may have progressive hippocampal volume loss and should be followed more closely with MRI and cognitive evaluation.
PisetskyDSGilkesonGSt ClairEW. Systemic lupus erythematosus. Diagnosis and treatment. Med Clin North Am1997; 81: 113–128.
2.
Pons-EstelGJAlarcónGSScofieldL. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum2010; 39: 257–268.
3.
AppenzellerSRondinaJMLiLM. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum2005; 52: 2783–2789.
4.
AppenzellerSBonilhaLRioPA. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. Neuroimage2007; 34: 694–701.
5.
AppenzellerSCarnevalleADLiLM. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis2006; 65: 1585–1589.
6.
CoanACKubotaBBergoFP. 3T MRI quantification of hippocampal volume and signal in mesial temporal lobe epilepsy improves detection of hippocampal sclerosis. Am J Neuroradiol2014; 35: 77–83.
7.
KubotaBYCoanACYasudaCLCendesF. T2 hyperintense signal in patients with temporal lobe epilepsy with MRI signs of hippocampal sclerosis and in patients with temporal lobe epilepsy with normal MRI. Epilepsy Behav2015; 46: 103–108.
8.
SuemitsuLAYasudaCLMoritaME. Longitudinal analysis of hippocampal T2 relaxometry in FMTLE. Epilepsy Behav2014; 36: 154–158.
9.
BronenRACheungGCharlesJT. Imaging findings in hippocampal sclerosis: correlation with pathology. Am J Neuroradiol1991; 12: 933–940.
10.
Van PaesschenWConnellyAKingMD. The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study. Ann Neurol1997; 41: 41–51.
11.
Van PaesschenWReveszTDuncanJS. Quantitative neuropathology and quantitative magnetic resonance imaging of the hippocampus in temporal lobe epilepsy. Ann Neurol1997; 42: 756–766.
12.
CendesFAndermannFGloorP. MRI volumetric measurements of amygdala and hippocampus in temporal lobe epilepsy. Neurology1993; 43: 719–725.
13.
JacksonGDConnellyADuncanJS. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology1993; 43: 1793–1799.
14.
WatsonCJackCRJrCendesF. Volumetric magnetic resonance imaging. Clinical applications and contributions to the understanding of temporal lobe epilepsy. Arch Neurol1997; 54: 1521–1531.
15.
BriellmannRSKalninsRMBerkovicSFJacksonGD. Hippocampal pathology in refractory temporal lobe epilepsy: T2-weighted signal changes reflect dentate gliosis. Neurology2002; 58: 265–271.
16.
TanEMCohenASFriesJF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
17.
ACR Ad Hoc Committee on Neuropsychiatric LupusACR. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum1999; 42: 599–608.
18.
FolsteinMFFolsteinSEFolsteinPR. “Mini mental state”: a practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res1975; 12: 189–198.
19.
SpranoelHZ. The psychoeducational use and interpretation of the Wechsler Adult Intelligence Scale – revised, Springfield: CC Thomas, 1992.
20.
Wechsler D. Wechsler Intelligent scale for adults. Helsinki: Psykologien Kustannus, 1986.
21.
DelisDCKramerJHKaplanEOberBA. California verbal learning test research edition manual, San Antonio: The Psychological Corporation, 1987.
22.
LezakMD. Neuropsychological assessment, New York: Oxford University Press, 1995.
23.
HeatonRKCheluneGJTalleyJL. Wisconsin Card Sorting Test Manual, revised and expanded, Odessa: Psychological Assessment Resources, 1993.
24.
BeckATBeamesderferA. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry1974; 7: 151–169.
25.
BeckATRialWYRickelsK. Short form of depression inventory: cross-validation. Psychol Rep1974; 34: 1184–1186.
26.
HerrmannC. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res1997; 42: 17–41.
27.
OverallJEBellerSA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research. I. Factor structure on an inpatient unit. J Gerontol1984; 39: 187–193.
28.
GladmanDDUrowitzMBKagalAHallettD. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol2000; 27: 377–379.
29.
IbañezDUrowitzMBGladmanDD. Summarizing disease features over time. I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. J Rheumatol2003; 30: 1977–1982.
30.
GladmanDDUrowitzMBGoldsmithCH. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum1997; 40: 809–813.
31.
BonilhaLKobayashiECendesFLiLM. The importance of accurate anatomic assessment for the volumetric analysis of the amygdala. Braz J Med Biol Res2005; 38: 409–418.
32.
WatsonCAndermannFGloorP. Anatomic basis of amygdaloidal and hippocampal volume measurement by magnetic resonance imaging. Neurology1992; 42: 1743–1750.
33.
BrunnerRSchaeferDHessK. Effect of corticosteroids on short-term and long-term memory. Neurology2005; 64: 335–337.
34.
PostalMCostallatLTAppenzellerS. Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management. CNS Drugs2011; 25: 721–736.
35.
GaoYLauEYWanJH. Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study. Lupus2016; 25: 637–644.
36.
ZimmermannNCorrêaDGKuboTA. Global cognitive impairment in systemic lupus erythematosus patients: a structural MRI study. Clin Neuroradiol2015; 13: 1–7.
37.
LauvsnesMBBeyerMKKvaloyJT. Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-d-aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren’s syndrome. Arthritis Rheumatol2014; 66: 3387–3394.
38.
BriellmannRSKalninsRMBerkovicSFJacksonGD. Hippocampal pathology in refractory temporal lobe epilepsy: T2-weighted signal change reflects dentate gliosis. Neurology2002; 58: 265–271.
39.
LenczTMcCarthyGBronenRA. Quantitative magnetic resonance imaging in temporal lobe epilepsy: relationship to neuropathology and neuropsychological function. Ann Neurol1992; 31: 629–637.
40.
LeeNTienRDLewisDV. Fast spin-echo, magnetic resonance imaging-measured hippocampal volume: correlation with neuronal density in anterior temporal lobectomy patients. Epilepsia1995; 36: 899–904.
41.
CascinoGDJackCRParisiJE. Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol1991; 30: 31–36.
42.
BouilleretVNehligAMarescauxCNamerIJ. Magnetic resonance imaging follow-up of progressive hippocampal changes in a mouse model of mesial temporal lobe epilepsy. Epilepsia2000; 41: 642–650.
43.
BarnesDMcDonaldWIJohnsonG. Quantitative nuclear magnetic resonance imaging: characterization of experimental cerebral oedema. J Neurol Neurosurg Psychiatry1987; 50: 125–133.
44.
BarnesDMcDonaldWILandonDNJohnsonG. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain1988; 111: 83–94.
45.
WieshmannUCWoermannFGLemieeuxL. Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus. Epilepsia1997; 38: 1238–1241.
46.
JacksonGDChambersBRBerkovicSF. Hippocampal sclerosis: development in adult life. Dev Neurosci1999; 21: 207–214.
47.
ParentJMYuTWLeibowitzRT. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci1997; 17: 3727–3738.
48.
PitkänenALaaksoMKälviäinenR. Severity of hippocampal atrophy correlates with the prolongation of MRI T2 relaxation time in temporal lobe epilepsy but not in Alzheimer’s disease. Neurology1996; 46: 1724–1730.
